ArticlePloS one2025
Efficacy of superimposing neuromuscular electrical stimulation onto core stability exercise in patients with nonspecific low back pain: A study protocol for a randomized controlled trial.
Article in PloS one, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
6 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
introductionNon-specific low back pain (NSLBP) is a prevalent condition affecting individuals worldwide, leading to significant disability and healthcare costs. Traditional treatment methods have shown limited efficacy, prompting the exploration of innovative approaches. Core stability exercise (CSE) has emerged as a promising rehabilitation strategy, yet optimal activation of local muscle systems remains to be fully understood. This trial aims to assess the efficacy of superimposing neuromuscular electrical stimulation (NMES) onto CSE for improving muscle activation, function, and proprioception in NSLBP patients. METHODS AND ANALYSIS: A total of 52 participants aged 18-60 years with NSLBP will be randomly allocated into two groups: (1) experimental group receiving NMES superimposed on CSE and (2) control group undergoing the same CSE with sham NMES. Interventions will occur three times per week for six weeks. The primary outcome measures will encompass surface electromyography (sEMG) to assess muscle activity and muscle activation timing. Secondary outcomes will include the evaluation of pain intensity using the Visual Analog Scale (VAS) and disability measured by the Oswestry Disability Index (ODI), as well as proprioception assessed through joint repositioning error (JRE) and muscle thickness evaluated via real-time ultrasound image (RUSI). Data will be collected at baseline, after six weeks, and at a six-month follow-up. A mixed ANOVA will be employed to compare differences among groups and to analyze trends over time as well as interaction effects between treatment and time.
trial registrationTrial registration number: Chinese Clinical Trial Registry (ChiCTR2400092409).
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.